FDA Approves Use Of J&J’s Single-Shot COVID Vaccine

The New York Times reports:

The Food and Drug Administration on Saturday authorized Johnson & Johnson’s single-shot Covid-19 vaccine for emergency use, beginning the rollout of millions of doses of a third effective vaccine that could reach Americans by early next week.

The announcement arrived at a critical moment, as the steep decline in coronavirus cases seems to have plateaued and millions of Americans are on waiting lists for shots. Johnson & Johnson has pledged to provide the United States with 100 million doses by the end of June.

When combined with the 600 million doses from the two-shot vaccines made by Pfizer-BioNTech and Moderna slated to arrive by the end of July, there will be more than enough shots to cover any American adult who wants one.

Read the full article.

Breaking News: The FDA authorized Johnson & Johnson’s coronavirus vaccine, the first that requires only a single shot. Distribution is expected to begin soon. https://t.co/d8P6Jfi3sM

— The New York Times (@nytimes) February 27, 2021